Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIT-2: CDDP plus S-1 with concurrent radiotherapy followed by surgery in stage IIIA-N2 squamous NSCLC
jRCTs031180403Phase 2Completed
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cisplatin and tegafur in Pulmonary squamous cell carcinoma. Primary endpoint: 2-year progression-free survival. Started Apr 2014; status: completed.
02
Drugs
cisplatintegafur
03
Conditions
Pulmonary squamous cell carcinoma
Beyond the preview
Go deeper on jRCTs031180403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180403.